Future Predictions for Intravenous and Subcutaneous Biologics

Opinion
Video

An expert in the field of rheumatology predicts how the treatment landscape will evolve for intravenous and subcutaneous therapies.

Video content above is prompted by the following questions:

  • How has the introduction of IV biosimilars impacted your treatment decisions? Do you see a role for subcutaneous biosimilars in the future?
  • Do you foresee IV and subcutaneous route of administration always having a role moving forward? How do you see the treatment landscape changing?


Recent Videos
1 KOL is featured in this series.
Jennifer Seminerio, MD, a gastroenterologist
Jennifer Seminerio, MD, a gastroenterologist
1 KOL is featured in this series.
Jennifer Seminerio, MD, a gastroenterologist
Jennifer Seminerio, MD, a gastroenterologist
1 KOL is featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.